mRNA Technologies, Therapeutics and Vaccines Digital Week
June 28-30, 2021
A complimentary 3-day webcast series where Industry leaders and service providers will showcase the power and diversity of mRNA technologies and applications across discovery/R&D, manufacturing and delivery.
TIDES Digital Week
A complimentary 4-day webinar series where industry leaders and service providers uncover leading strategies for expediting R&D and improving CMC efficiency.
Hybrid Event: September 20-30, 2021
Live Event: September 20-23 in Boston, MA
The industry's largest & most renowned event to accelerate your therapeutics to market. Leading strategies for expediting R&D and improving CMC efficiency. Unparalleled access to new data & case studies from globally recognized speakers across the entire landscape of oligonucleotides, peptides, mRNA, genome editing, drug delivery, and partnerships – from discovery to market.
November 2-5, 2021 | Vienna, Austria
The industry's leading event in Europe to accelerate therapeutics to market by expediting R&D, improving CMC efficiency, and building new partnerships. Access new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies -- from discovery to market, with an emphasis on the European region.
Introduction to Analytical Control Strategies for Therapeutic Oligonucleotides from Early Development to Registration
Learn how to develop an evolving control strategy for your drug substance — from early development to registration. The course will also discuss the issues and risks that can be developed, addressed and mitigated during development
Introduction to Oligonucleotide Conjugate Strategies
Understand how to best design oligonucleotide conjugates — from simple starting building blocks to the full oligonucleotide conjugate. With full consideration of the biological behavior of both the finished molecule and all of its individual components.
Expert Opinion Webinars
Characterization of Shared Immunogenic Frameshift Mutations in Cancers with Microsatellite Instability
Sponsored by Genscript
Wednesday, July 21 @ 11:00am EST
-Dr. Cansu Cimen Bozkus, Icahn School of Medicine at Mount Sinai